Fundamental Analysis
15 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -302.2% | -144.8% | 0 / 3 | -10.3% | -9.43 pp | -14.93 pp | +0.1% | 0.42 | 368.49 | 194 | −10,3% | −20,1 | −302,2% | 368.49 | 5.06 | +7.182,4% |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 6.100 (close price on 2026-10-20)EPS (TTM): 16,6
Financial charts
1.Revenue & growth
VND bn194Q2/26
1.Revenue & growth
VND bn194Q2/26
2.Profit & growth
VND bn-20,1Q2/26
3.Profit mix (Penman)
VND bn6,24Q2/26
4.Margins & cost structure
%19.8%Q2/26
5.Returns & cash cycle
% · days-0.0%Q2/26
6.Earnings quality & cash
VND bn188Q2/26
7.Asset structure
VND bn1.716Q2/26
8.Funding & debt health
VND bn · times1.716Q2/26
9.Revenue backlog
VND bn2,83Q2/26
10.Valuation
times · %368,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-296Q2/26
Adjusted EPS growth, latest quarter
-302%
Average adjusted EPS growth, 3 quarters
-145%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26